It is not easy to reach a differential diagnosis between keratoacanthoma (KA) and squamous cell carcinoma (SCC) and furthermore there is still considerable discussion about the relationship of these 2 tumors with immunity. To facilitate such a diagnosis, we assessed the Glut-1 antibody, reported to be strongly and diffusely expressed in SCC but never assessed in KA. We studied 43 lesions of immunocompetent patients: 17 SCCs, 13 typical KAs (tKAs), and 13 atypical KAs (aKAs), with histologic features of SCC in less than 30% of the lesions. In tKA, Glut-1 stained only the basal layers of the squamous nests (basal pattern) whereas in SCC the squamous nests were randomly and diffusely stained (diffuse pattern). In aKA, a biphasic pattern was observed, with the typical KA areas showing the basal pattern and the SCClike areas showing the diffuse pattern. Glut-1, therefore, helps to distinguish tKAs from SCCs and highlights the intermediate aKA group, supporting the hypothesis of a progression from KA to SCC. Finally, we used CD1a, CD57, CD4, CD8, CD3, and CD20 antibodies to assess whether or not the progression might be related to an in situ immunologic deficit. Significant differences were found both in CD1a + cells, more numerous in tKA than in SCC and in CD57 + cells, more numerous in tKA than in aKA and in SCC. This suggests a local immunological failure in aKA and SCC, probably related to the action of UV rays, leading us to consider KA as a model for the study of the interaction of skin cancer and immunity.
K eratoacanthoma (KA) is a proliferative squamous lesion of uncertain histogenesis, clinically characterized by growth rapidity and autoregression capacity. In its more typical appearance, it occurs on intact skin, grows rapidly over 4 or 6 weeks, then regresses spontaneously in a similar period of time, leaving a slightly depressed annular scar. 1 The main differential diagnosis is with squamous cell carcinoma (SCC) generally with the cup-shaped, histologically well-differentiated type, and even though several features have been reported for discriminating between the 2 lesions, their clinical and histologic aspects often overlap. Rapid growth and capacity of regression, for example, are features of KA, but certain KAs do not regress and at times grow slowly, while other SCCs may grow rapidly. Furthermore, some Kas present histologic aspects which are more typical of SCC, such as atypias, perineural or vascular infiltration, or extension to the underlying skeletal muscles. 1 The presence of actinic keratosis, more frequently reported in the skin surrounding SCC, is often observed also in the skin adjacent to KA. Finally, there have been no reports in literature regarding immunohistochemical markers which might reliably discriminate KA from SCC. 2, 3 Thus, despite the fact that KA and SCC have been considered as two separate entities for so long, [4] [5] [6] the presence of overlapping features and the possibility of malignant transformation, especially in older patients and in photoexposed areas, 7 has recently led to the hypothesis that the two neoplasias might well represent the 2 extreme ends of the same spectrum, with the possibility of evolution of KA toward SCC. [8] [9] [10] [11] [12] [13] In contrast, when the SCC is small and is adequately treated, the prognosis is excellent, similar to that of KA. Even with follow-up, therefore, it is not possible to discriminate between the 2 entities and in most cases, surgical excision does not offer any comprehension of their natural histories. In the effort to reach a clearer understanding of the real nature of KA and its probable link with SCC, we focused on the antibody anti-Glucose Transporter-1 (Glut-1), which looks to be aberrantly expressed in most SCCs [14] [15] [16] and presents a low expression in normal skin. Glut-1 is an integral membrane glycoprotein facilitating glucose transport in many cells and its overexpression has been considered as an early event of carcinogenesis. 14 Up till now, there have been no reports in literature regarding Glut-1 expression in KA. We studied Glut-1 expression in KA and in SCC to assess whether or not they show a different pattern of expression.
Finally, in consideration of the important role attributed to immunity deficit in the development of neoplasias, we studied some of the most important components of the inflammatory infiltrate of these 2 lesions. We assessed the B-cell component, the T-cell component, (respectively by using CD20 and CD3 antibodies), some of the most important T-cell subpopulations (by using CD4, CD8, and CD57 antibodies) and the presence of the dendritic cells (by using the anti-CD1a antibody).
The dendritic cells are accessory cells of the immune system and are considered to be the best Antigen Presenting Cells (APC), playing a major role in the induction of antitumoral immune response against protein antigens. They express receptors such as CD1a and S100 on their surface and are the most capable vehicles for capturing specific tumor antigens. Examples are the Langerhans cells of the skin, whose main function is to capture the protein antigens and to transport them to the draining lymph nodes where, in association with the Major Histocompatibility Complex (MHC) molecules of class II, they will be presented to CD4 + T lymphocytes. The number of Langerhans cells increases in the cancer adjacent areas and decreases with advancing tumor stage. 17 It is noteworthy that they have been observed in KAs where they prove to be present at all stages, suggesting that they may play a role in the regression of this lesion. 18 The role of T helper lymphocytes CD4 + is not entirely clear; probably they are involved in the antitumoral response by producing cytokines stimulating the effector CD8 + Cytotoxic T Lymphocytes (CTL). CD8 + CTL play the main role in the killing off of neoplastic cells by inducing apoptosis.
Natural Killer (NK) cells are a lymphocyte subpopulation characterized by some surface markers such as the adhesion molecules CD56 and CD57. They are able to kill off both the virus-infected cells and the tumoral cells by secreting cytokines and are inhibited by class I molecules expressing cells. If MHC I molecules on target cells are disrupted by viral infection or neoplastic transformation, no inhibitor signals are sent to NK cells and cell lysis can take place. In consideration of the often similar histologic features of SCC and KA, and despite their different, opposite fate, the aim of our study was to assess whether or not in immunocompetent patients these two lesions show some alterations in several components of the local skin immunity with special attention to the CD1a + dendritic component and to the CD57 + Natural Killer (NK) component.
MATERIALS AND METHODS
The study was conducted retrospectively on 43, cutaneous cup-shaped neoformations, surgically excised and submitted to the "Department of Human Pathology," University of Palermo from January 1, 2007 to January 2, 2009. Clinical features of all the lesions (age, sex, location of the lesion, mean diameter, time from onset) were reported and the stored slides, stained with hematoxylin-eosin, were reobserved.
Of these, 26 had an earlier diagnosis of KA and 17 had a diagnosis of well-differentiated SCC. The histologic diagnosis of KA was confirmed for all the cases (26/26).
Nevertheless, 13 out of 26 cases entirely fulfilled both clinical and histologic criteria for KA diagnosis 2 and were classified as "typical KA" (tKA).
The remaining 13 cases showed focal areas with some features overlapping those of SCC, consisting of a higher degree of cytologic atypia, a higher nuclear/cytoplasmic ratio, several, sometimes atypical, mytosis and focal aspects of irregular infiltration at the deep boundary level. When these features were limited to less than 30% of the whole neoplasia, which, for the most part, fulfilled the histologic aspects of KA, they were interpreted as "atypical KA" (aKA).
Immunohistochemical Evaluation
Immunohistochemical studies were conducted by means of the avidin-biotin-complex (ABC) technique. The primary monoclonal antibodies (mABs) used in this study were anti Glut-1, anti-CD1a (DAKO, 1:50), anti-CD20, anti-CD3, anti-CD57 (Novocastra, 1:50), anti-CD8 (Novocastra, 1:40), anti-CD4 (Novocastra, 1:40). Sections were cut from 10% formalin-fixed, paraffinembedded materials. After dewaxing, the slides were microwaved 3 times for 5 minutes in Citrate pH 6.0 buffer (heat-induced epitope retrieval) and were then washed with phosphate-buffered saline (PBS); the endogenous peroxidase activity was inhibited by pretreatment with hydrogen peroxide before incubation with the primary antibody. Sections were subsequently incubated with the primary antibody overnight at 41C, the specimens were then incubated with the LSAB HRP detection kit (Universal DakoCytomation LSAB+ System HRP) at room temperature, according to the manufacturer's instructions. The sections were washed twice in PBS 5 minutes for each one; after all the incubation steps. 3-amino-9-ethylcarbazole (AEC) and diaminobenzidine (DAB) were used as a chromogen for 5 minutes at room temperature with subsequent nuclear counterstaining with Mayer's hematoxylin. The erithrocytes and the adjacent epidermic Langerhans cells were used respectively as internal positive controls for Glut-1 and CD1a immunostaining. For CD20, CD3, CD4, CD8, and CD57 immunostaining, the presence in the inflammatory infiltrate of 1 positive lymphocyte X HPF in at least 3 HPF, was evaluated as an internal positive control. Finally, negative controls without primary antibodies were included in each run of immunohistochemistry.
Cell Counting
Immunohistochemically stained sections were observed with an optical microscope. For each antibody, we observed at 20 Â , 10 microscopic fields in which squamous neoplastic nests were predominant. Glut-1 expression was qualitatively and quantitatively assessed. Two qualitatively different immunostaining patterns were observed: the first consisted of peripheral positive immunostaining, limited to the basophil, nonkeratinizing basal layers of the squamous epithelial nests defined as a "basal pattern"; the second consisted of randomly and diffusely distributed immunostaining, present both in the basal layer cells and in the central squamous cells of the nests. When this pattern was present in more than 30% of the squamous areas we defined it as a "diffuse pattern." When it was present in less than 30% of the squamous nests, with the basal pattern prevalent and often coexistent in the same microscopic field, we referred to it as a "biphasic pattern."
The presence of CD1a and CD57 positive cells was quantitatively evaluated, taking into account their intratumoral and peritumoral distribution. For CD20 + , CD3 + , CD4 + , and CD8 + cells, a semiquantitative evaluation was performed and the results were expressed as a percentage of the infiltrating inflammatory population: ± (0 to 25%); +(25 to 50%); ++(50 to 75%); +++(75 to 100%).
Statistical Analysis
Statistical analysis was done by using the software GraphPad Prisma 5. The peritumoral and intratumoral positive cell distibution was compared in the 3 groups by using the Mann-Whitney U test for CD1a and CD57 antibodies and the t paired test for CD20, CD3, CD8, and CD4 antibodies. In both tests a P value <0.05 was considered statistically significant.
RESULTS
The head and neck were the more frequent locations in all the 3 groups (10/13 tKA, 9/13 aKA, 13/17 SCC). The M/F ratio was 4:1 for tKA and for aKA and 5:1 for SCC. The age was more advanced in SCC and aKA compared with tKAs (tKA = 63; range: 22 to 80; aKA = 73 range: 43-79; SCC = 74 range: 52 to 92). Typical KAs were smaller than aKA and SCC (KA mean diameter: 0.94 cm, range: 0.6 to 1.3 cm; aKA mean diameter = 2 cm, range 0.8 to 4 cm; SCC mean diameter = 1.58 cm, range: 0.3 to 4.5 cm).
In tKA, 11 out of 13 cases showed a diameter <1 cm, whereas in aKA 9 out of 13 cases showed a diameter greater than 1 cm. tKA presented a shorter time from onset than aKA and SCC (respectively 3 months: range 1 to 4; 14 mo: range 0.3 to 72; 31 mo: range 1.5 to 240). The data regarding sex, age, time from onset, and mean diameter are reported in Table 1 . In tKAs, Glut-1 immunostaining showed a "basal pattern" consisting of a continuous peripheral positivity limited to the basophil, nonkeratinizing basal layers of the squamous nests and with a clear separation from the central layers, which stained negatively for Glut-1 immunostaining (Fig. 1A) . This "basal pattern" was present in all the squamous nests and no areas with Glut-1 "diffuse pattern" were observed. On the contrary, in SCCs, Glut-1 immunostaining showed a "diffuse pattern" interesting both the basal and the central layers of the squamous nests, with randomly distributed positive cells, often intermingled with the negative ones (Fig. 1B) . This pattern was present in more than 30% of the squamous nests and in most of the SCCs (13/17) it was present in more than 80% of the nests, with the basal pattern limited to the remaining scanty areas. The aKA cases showed a Glut-1 biphasic expression, with a basal pattern, similar to that of tKAs, in the majority of the areas (from 70% to 95% of the entire lesion) which also showed histologic features typical of KA (Table 2) . The "diffuse pattern" was evident in the remaining areas (from 5% to 30%, of the tumor) which also showed some histologic worrisome features reminiscent of SCC (namely, a higher degree of cytologic atypia, a higher nuclear/cytoplasmic ratio, several mitoses, and irregular deep infiltration). The different patterns were often coexistent in the same microscopic field (Fig. 1C) .
The number of peritumoral and intratumoral CD1a + cells increased in tKA compared with SCC (mean number of intratumoral CD1a+ cells: tKA = 34; range 12 to 80; SCC = 16, range 5 to 27; P<0.05; mean number of peritumoral CD1a+ cells: tKA = 20, range 4 to 35; SCC = 6, range 0 to 28; P<0.05) ( Figs. 2A, B) .
In aKA the mean number of intratumoral CD1a + cells was 26 (range 0 to 54) and that of the peritumoral CD1a + cells was 15 (range 3 to 40). When comparing tKA with aKA and aKA with SCC, the number of CD1a cells decreased progressively, but the difference was not statistically significant in either of these comparisons (P>0.05). The CD1a results are reported in Figures 3A  and B . The mean number of peritumoral CD57 + cells in tKA was significantly higher than in SCC (tKA mean number = 19, range 1 to 56; SCC mean number = 5, range 0 to 25; P = 0.02) and than in aKA (aKA mean number = 6, range 0 to 28; P = 0.018) (Figs. 4A, B) . On the contrary, no statistically significant differences were observed between aKA and SCC in the mean numbers of peritumoral and intratumoral CD57 + cells. The mean number of intratumoral CD57 + cells was extremely low in all the groups (in tKA and aTKA = 2; in SCC = 1) without any significant difference. The CD57 results are reported in Figures 5A and B .
Finally, the statistical analysis of the semiquantitative assessment of CD20 + , CD3 + , CD4 + , and CD8 + cells did not show any significant difference in any of the comparisons. Table 3 summarizes the comparison of the statistical significance tests of the different groups.
DISCUSSION
Continual debate regarding keratoacanthoma has been going on since the 1950s. It is still not clear whether or not it is always a self-regressing lesion or whether, under specific conditions, it is able to progress into an invasive squamous cell carcinoma. 19 There are 2 main schools of thought, the first suggesting that KA and SCC are 2 separate entities, with KA being a benign lesion, characterized by spontaneous regression and SCC being a malignant lesion capable of relapsing and metastasizing. 4, 5, 20 The second idea is that KA and SCC are different entities of the same disease spectrum, with a dynamic relationship between them. [8] [9] [10] [11] Sometimes, in fact, it is impossible to distinguish KA from squamous cell carcinoma (SCC) owing to the clinical and histologic overlapping between them. 2, 9, 12 Several studies have attempted to find other methods for a more accurate distinction between KAs and SCCs. A variety of stains and tests have been investigated, such as the expression of several biomarkers, for instance vascular cell adhesion molecule (VCAM), intercellular adhesion molecule (ICAM), angiotensin type 1 receptor, p53, proliferating cell nuclear antigen, telomerase, cyclo-oxygenase-2 (COX-2), Ki-67, transforming growth factor a peanut lectin receptor, MIB-1, p16 INK4a. 18, [21] [22] [23] [24] [25] [26] [27] Unfortunately, none of these methods has been proven to be specific and reliable in distinguishing between KAs and SCCs. 2, 3 In our study Glut-1 showed a different pattern between the tKA group, in which it stained with the "basal pattern" and the SCC group, in which it stained with the "diffuse pattern," which helped to confirm the diagnosis of true KAs and supported the idea that true KAs do in fact exist and really differ from SCCs also with regard to their monotonous, continous Glut-1 expression pattern, limited to the basal layers of the nests.
Nevertheless, Glut-1 immunostaining highlighted the presence of the aKA group, in which it showed a biphasic pattern, with most areas showing a "basal pattern" as in tKA (it is noteworthy that these areas also showed histologic features typical of KA) and some atypical areas showing diffuse and random staining of the squamous nests, as in SCC. We arbitrarily established a cut-off of 30% for these atypical areas since, in our experience, when these were more extensively represented, the histologic differential diagnosis with SCC became more difficult. At the present time, we obviously cannot establish the exact percentage cut-off of the atypical areas at the point where each lesion stops being benign and should be defined as an SCC, since, as mentioned earlier, when small SCCs are correctly removed, their prognosis does not differ substantially from that of KAs.
Traditional clinical, morphologic criteria and Glut-1 immunohistochemical results might therefore lead to the conclusion that sometimes the distinction between KA and SCC is difficult, due to the existence of the aKA group, which seems as a "borderline" entity. For this group, there might be a progression to SCC, by diverging from the fate of spontaneous regression prefigured for KA, which might be based on immunologic factors.
In fact, the link between spontaneous regression, a phenomenon present in a variety of cutaneous lesions, and immunologic mechanisms, has been reported in several previous studies. Some epidemiological studies suggest that immunosuppressed transplanted patients present a higher risk of developing tumors than immunocompetent patients. This might be related to the lack of control on the action of some oncogenetic agents, for example, several viruses, such as the Human Papilloma Virus (HPV) owing to general immunosuppression. [28] [29] [30] [31] [32] In contrast, in immunocompetent patients harboring cutaneous neoplasias, a local deficit (in situ) of the immune system, related to UV radiation, has been suggested. Epidemiologic studies have shown that sun UV rays induce an increased incidence of squamous cell carcinoma, 33 owing to a number of effects on the cells, including inhibition of cell division, mutations in oncogenes and tumor suppressor genes and, noteworthy, alterations in immunity brought about by the suppression of antitumoral responses. It has been shown, in fact, that UVR may inhibit antigen presentation by dendritic cells, both directly and indirectly via the induction of suppressive cytokines. [34] [35] [36] It is interesting to note that the exposure to ultraviolet radiation is the risk factor most commonly associated with KA and SCC pathogenesis. 33 The cell-mediated component is the main mechanism of anticancer immunity, through the action of cytotoxic T Lymphocytes (CTL) CD8 + and of Natural Killer cells (NK), present in the inflammatory infiltrate surrounding many tumors. The presence of a lymphocytic infiltrate is a favorable prognostic indicator in many tumors, such as melanomas, 37 head and neck tumors, 38 colon cancer, 39, 40 etc.
As our own study involved a great number of CD20 + , CD3 + , CD4 + , and CD8 + cells, a quantitative assessment was not carried out for these antibodies and the semiquantitative assessment of the positively stained cell populations did not show any statistically significant differences among the 3 groups. This might represent a limit of subjective semiquantitative evaluation and an automated cell count, with the use of an automated analyzer, might be more appropriate. On the contrary, we found that intratumoral and peritumoral CD1a + cells, quantitatively assessed, are significantly more numerous in tKA than in SCC (P<0.05). These results are in keeping with a recent article, which reported a higher S100+ LC density in benign cutaneous tumors compared with their malignant counterparts. 41 When comparing tKA with aKA and aKA with SCC, the CD1a cell number decreased progressively, and although there were no statistically significant differences in either of these comparisons, the progressive decrease suggest a continuum, with aKA appearing as a transition group between tKA and SCC.
The peritumoral CD57 + NK cells were significantly more numerous in tKA when compared with SCC and with aKA (respectively P = 0.02 and P = 0.018) but no significant difference was found between aKA and SCC, where such cells were very scarce.
With regard to CD57+ cells, therefore, aKA resembles SCC, suggesting that an early deficit of local immunity has already occurred in them. This might be responsible for a local control failure on cells undergoing malignant transformation. It is interesting to note, in fact, that in aKA, several clinical, histologic, and immunohistochemical deviations from the typical features of KA have already taken place, at least focally, suggesting a local immunodeficit probably responsible for the action of permissive mechanisms towards potential carcinogenetic agents, such as UV rays or HPV infections.
A deficiency of local immunity with the reduction CD1a + cells has been reported earlier in immunodeficient patients with neoplastic lesions of the vulva and vagina, in which it has been suggested that it may help to strengthen the oncogenetic role of HPV. 42 In conclusion, in our study, Glut-1 proved to be useful for confirming the diagnosis of true KAs, for distinguishing them from SCC and for reaching a clearer understanding of the real nature of KA by highlighting the existence of the intermediate, borderline, aKA group. We, therefore suggest that KA may regress as the result of functioning immunity, but in the presence of a deficit of local immunity, such as, for example, the reduction of CD1a + and CD57 + cells, even in immunocompetent patients, some KAs might develop into SCCs. Several further studies are at present in course in our laboratories, with the aim of assessing other components of cellmediated immunity, such as the T-reg population. From this point of view, KA might represent an interesting model for the study of the interaction mechanisms between skin cancer and immunity. 
